Score Media And Gaming Inc. - S (NASDAQ:SCR)

We are a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer drug Endu in the rapidly growing China market. Our strategic focus is to introduce first-to-market generic and innovative pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate and for which there is a clear demand for more effective pharmacotherapy, such as the introduction of our first-to-market generic stroke management medication Bicun and our anti-cancer medication Endu (also known as “Endostar").

We currently manufacture and sell more than 50 pharmaceutical products and are the exclusive distributor of three additional pharmaceutical products marketed under our brand name. Our products range from medications for the treatment of cancer, cerebrovascular diseases, infections, arthritis and diarrhea to medications for the treatment of allergies, respiratory conditions and urinary conditions. Our credo "Respect People, Respect Life" demonstrates our commitment to high standards of integrity in contributing to the best interests of patients, the medical profession, our employees and our communities, and to seek significant returns to our shareholders, based on the continual pursuit of scientific and operational excellence.